Comment from the EditorsTranslational Research: The Study of Community Effectiveness in Digestive and Liver Disorders
References (11)
- et al.
Statistical discrimination in health care
J Health Econ
(2001) - et al.
Prejudice, clinical uncertainty and stereotyping as sources of health disparities
J Health Econ
(2003) - et al.
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study
J Hepatol
(2006) Crossing the quality chasm
(2001)- et al.
Implementing the institute of medicine definition of disparities: an application to mental health care
Health Serv Res
(2006)
There are more references available in the full text version of this article.
Cited by (20)
Diagnosis and Treatment of Hepatocellular Carcinoma
2008, GastroenterologyCitation Excerpt :To make a positive impact on the effectiveness of treating HCC, several steps have to be successfully accomplished so that more patients can be diagnosed at an early stage and receive timely potentially curative therapy. However, there seems to be a serious chasm between efficacy and effectiveness of treatment of HCC.100 A United States population-based study reported that, in 2963 patients 65 years and older diagnosed between 1992 and 1999 with HCC, only 13% received potentially curative therapy (transplant, 0.9%; resection, 8.2%; local ablation, 4.1%).
Monitoring one-carbon metabolism by mass spectrometry to assess liver function and disease
2022, Journal of Physiology and BiochemistryHepatitis d virus and hepatocellular carcinoma
2021, VirusesLiver cancer-associated changes to the proteome: what deserves clinical focus?
2018, Expert Review of ProteomicsPrioritizing Popular Proteins in Liver Cancer: Remodelling One-Carbon Metabolism
2017, Journal of Proteome ResearchHuge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C
2015, Medicine (United States)
Copyright © 2007 AGA Institute. Published by Elsevier Inc. All rights reserved.